Proteolytic cleavage of huntingtin gives rise to N-terminal fragments. While the role of truncated mutant huntingtin is described in Huntington's disease (HD) pathogenesis, the function of N-terminal wild-type protein is less studied. The yeast model of HD is generated by the presence of FLAG tag and absence of polyproline tract as flanking sequences of the elongated polyglutamine stretch. We show that the same sequence derived from wildtype huntingtin exon1 is able to inhibit the aggregation of proteins in vitro and in yeast cells. It is able to stabilize client proteins as varied as luciferase, a-synuclein, and p53 in a soluble but non-native state. This is somewhat similar to the 'holdase' function of small heat shock proteins and 'nonchaperone proteins' which are able to stabilize partially unfolded client proteins in a nonspecific manner, slowing down their aggregation. Mutagenesis studies show this property to be localized at the N17 domain preceding the polyglutamine tract. Distortion of this ordered segment, either by deletion of this segment or mutation of a single residue (L4A), leads to decreased stability and increased aggregation of client proteins. It is interesting to note that the helical conformation of the N17 domain is also essential for aggregation of the N-terminal mutant protein. Our results provide evidence for a novel function for the amphipathic helix derived from exon1 of wild-type huntingtin.
Introduction
Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder caused by the expansion of CAG triplet repeat in exon1 of huntingtin (htt) gene leading to a mutant protein with extended polyglutamine (polyQ) tract [1] . Mutant huntingtin undergoes successive site-specific proteolysis by caspases and calpains, forming toxic N-terminal fragments which harbor the elongated polyQ segment [2, 3] . Aberrant splicing of the huntingtin transcript may also give rise to the N-terminal fragment [4] . The level of these unspliced exon 1-intron 1 transcripts is proportional to the length of the polyQ tract. The binding site of the splicing factor SRSF6 was mapped to a CAG/ CAGCAA repeat sequence, which might explain the observed polyQ-length dependence of aberrant splicing. These are exemplified by the R6 transgenic mouse HD model [5] . The truncated protein may enter the nucleus and form inclusions. Aggregates are also formed in the cytosol. The role of aggregation remains ambiguous [6] although both nuclear and cytoplasmic aggregates have been positively correlated with progression of the disease [7] . Establishment of an exact cause-and-effect relationship between aggregation of mutant huntingtin (m-htt) and disease pathogenesis has proven to be difficult. Transcriptional dysregulation, disruption of protein trafficking, mitochondrial dysfunction, sequestration of essential proteins, etc. are presumed to result from aggregation of m-htt [7, 8] . As such, the structure and function of m-htt and its N-terminal domain have attracted considerable attention, with a view to ameliorate disease symptoms and eventually to develop a curative therapy.
The function of wild-type huntingtin (wt-htt) is not so well explored [9] . The protein is expressed ubiquitously in neuronal and non-neuronal cells and exhibits temporal and cell-specific effects. Patients homozygous with mutant alleles do not exhibit any birth-related anomaly [10] . Loss of wt-htt in juvenile mouse, however, is lethal; probably due to development of acute pancreatitis although its conditional depletion in adult mouse brain has no effect [11] . Earlier studies with conditionally knocked out mice had reported progressive neuronal and motor degeneration, accompanied by reduced survival [12] . Ablation of wt-htt was also embryonically lethal in mice [13] but not in Drosophila [14] . Instead, loss-of-function flies reported accelerated neurodegeneration and reduced survival. Studies in zebrafish have implicated wt-htt in cellular iron metabolism [15] . Overexpression of wt-htt provided protection to conditionally immortalized striatum-derived cells exposed to apoptotic stimuli and the anti-apoptotic function was localized in its N terminus [16] . Protection against ischemic injury in a mouse model was also reported [17] . Based on its structural similarity to yeast autophagy proteins and its ability to interact with various members of the autophagy cascade, the C-terminal domain of wt-htt is likely to be a participant in selective autophagy [18] .
Interestingly, wt-htt showed a cytoprotective role in neuronal and non-neuronal cells expressing m-htt [19] . Wt-htt was able to rescue testicular degeneration in mice expressing full-length m-htt [20] . On the other hand, m-htt was able to sequester wt-htt into SDS-insoluble aggregates [21] , supporting the loss-of-function hypothesis proposed for HD pathogenesis.
Sequestration was recently shown to be a dose-dependent effect of wt-htt [22] . Expression of wt-htt from a high copy number plasmid was able to solubilize m-htt and improve cell function and survival while expression from a low copy number plasmid led to its sequestration by m-htt aggregates in a yeast model. Even in the latter case, the presence of wt-htt exhibited beneficial effects on the cell phenotype [22] . The presence of the FLAG tag at either terminus of N-wt-htt [23] and deletion of the polyP segment at the C terminus of the polyQ tract [23, 24] is essential to generate the yeast model of HD. In this work, we have attempted to understand the function of the same construct but with a shorter length of polyQ stretch, as is present in wthtt. We show that this fragment has a role in the proteostasis network in the cell, which may be likened to that of a 'holdase' [25] . We present evidence that this function resides in the hydrophobic face of the N17 region of the protein, similar to the structural requirements of aggregation of m-htt in vitro [26] , and could be a property of the amphipathic helical peptide derived from exon1.
Results

Presence of N-terminal huntingtin leads to increased solubility of proteins in vitro
FLAG-N17-25Q-EGFP (Fig. 1A) was expressed in S. cerevisiae W303 cells under a galactose-inducible promoter and purified using anti-FLAG M2 affinity gel (Fig. 1B,C) . Luciferase was denatured with 5 M guanidinium HCl and diluted under different conditions as described in the Methods section [27] . Following dilution, samples were centrifuged and the presence of soluble luciferase was detected in the supernatant by immunoblotting (Fig. 1D) . No protein was recovered in the soluble fraction when the denatured protein was diluted in buffer alone showing that the protein had aggregated almost completely. As expected [27] , less than 50% luciferase could be recovered in the soluble fraction when incubated in the presence of trehalose. On the other hand, about 89% of luciferase could be detected in the soluble fraction after 6 h of incubation with FLAG-N17-25Q-EGFP (Fig. 1D) , indicating that the FLAG-N17-25Q-EGFP was able to suppress aggregation of luciferase. The suppression of aggregation of luciferase by FLAG-N17-25Q-EGFP was further verified by measuring the mean particle size of firefly luciferase by dynamic light scattering (Fig. 1E ). GdHCl-denatured luciferase diluted in buffer alone showed almost complete disappearance of monomeric luciferase (Table 1 ) and the appearance of a peak at higher molecular weight, indicating possible aggregation. In the presence of FLAG-N17-25Q-EGFP, a higher fraction of luciferase remained in the monomeric form (45.6% vs 11.1% when diluted in buffer alone) (Table 1) . Interestingly, a peak at lower particle size (28.61 nm) was also observed, indicating the presence of oligomers. It has been reported that shorter polyQ stretches of benign length do not aggregate at all or do so at much longer time scales than the ones used here [28] [29] [30] [31] . Thus, it may be inferred that in the presence of FLAG-N17-25Q-EGFP, luciferase forms low molecular weight oligomers and the aggregation of luciferase is suppressed. Purified firefly luciferase was denatured using guanidinium HCl, diluted into buffer alone and allowed to form aggregates at room temperature for 30 min (Fig. 1D ). This aggregated luciferase was further incubated with FLAG-N17-25Q-EGFP. Luciferase could not be detected in the soluble fraction under any condition (data not shown), indicating that FLAG-N17-25Q-EGFP was unable to reverse protein aggregation or to promote dissolution of pre-existing aggregates.
The renaturation of luciferase was measured by luminescence. The presence of FLAG-N17-25Q-htt-EGFP had no effect on the luminescence of luciferase (Fig. 1F) . The activity of luciferase solubilized in the presence of FLAG-N17-25Q-EGFP was found to be significantly reduced as compared with native luciferase (Fig. 1F) . Thus, the guanidinium HCl-unfolded protein diluted into buffer containing FLAG-N17-25Q-EGFP was maintained in a soluble but non-native state. The FLAG-N17-25Q-EGFP-solubilized luciferase fraction was incubated with rabbit reticulocyte lysate to investigate if supplementing the medium with cellular refolding agents [27] could reactivate the enzyme. Renaturation of GdHCl-denatured luciferase was used as the positive control [27] . The luciferase solubilized with FLAG-N17-25Q-EGFP showed 50% reactivation in the presence of rabbit reticulocyte lysate as compared with the positive control after 3 h of incubation with the supplemented medium (Fig. 1G) . The partial renaturation of luciferase indicates a stabilization mechanism by FLAG-N17-25Q-EGFP which hinders complete reactivation of the non-native monomer by cellular chaperones.
Thus, FLAG-N17-25Q-EGFP 'holds' the denatured luciferase in a nonaggregated (but non-native) conformation till the cellular chaperones rescue and renature the protein.
Fusion partner of N-terminal huntingtin is not required for increased solubility of proteins in vitro
In order to check if the presence of the reporter protein (EGFP) is necessary for solubility of luciferase in vitro, the EGFP tag in FLAG-N17-25Q-EGFP was replaced with mRFP which possesses different physicoand biochemical properties than EGFP. FLAG-N17-25Q-mRFP was expressed and purified from S. cerevisiae cells according to the protocol described for purification of FLAG-N17-25Q-EGFP and incubated with guanidinium HCl-denatured luciferase. Luciferase could be detected in the soluble fraction after 2 h and 6 h of incubation ( Fig. 2A) , indicating that FLAG-N17-25Q-mRFP was able to suppress aggregation of luciferase. Recovery of soluble luciferase after 6 h with FLAG-N17-25Q-mRFP was 83%, which was comparable to 89% in the presence of FLAG-N17-25Q-EGFP (Fig. 1D) . Hence, luciferase was present in the soluble form irrespective of the reporter tag fused with N17-FLAG-25Q. Solubilized luciferase was incubated with rabbit reticulocyte lysate as before to determine if supplementing the medium with cellular refolding agents [27] could reactivate the enzyme. Luciferase incubated with FLAG-N17-25Q-mRFP showed 34% renaturation in the presence of rabbit reticulocyte lysate as compared with the positive control (GdHCl-denatured luciferase) after 3.5 h of incubation with the supplemented medium (Fig. 2B) . In order to elucidate the mechanism by which FLAG-N17-25Q-EGFP was able to maintain luciferase in the soluble form, EGFP sequence was deleted from pYES2-FLAG-N17-25Q-EGFP to yield the vector pYES2-FLAG-N17-25Q. FLAG-N17-25Q (without any fluorescent protein tag) was expressed and purified from yeast cells using anti-FLAG M2 affinity gel as before. Purified FLAG-N17-25Q was incubated with guanidinium HCl-denatured luciferase and the soluble fractions were analyzed by immunoblotting. Luciferase could be detected in the soluble fraction at all time intervals of incubation ( Fig. 2C) , showing that FLAG-N17-25Q acted as a suppressor of aggregation. After 6 h, 86% of luciferase was recovered in the soluble fraction which was comparable to 89% and 83% soluble luciferase obtained in the presence of FLAG-N17-25Q-EGFP (Fig. 1D ) and FLAG-N17-25Q-mRFP ( Fig. 2A) , respectively. However, the soluble luciferase was enzymatically inactive (data not shown).
FLAG-N17-25Q was, thus, established as an inhibitor of aggregation, and the presence of a reporter tag was not a requirement for this activity.
Presence of N-terminal huntingtin leads to increased solubility of proteins in vivo Next, the activity of N-terminal huntingtin as an inhibitor of aggregation was checked in a cellular environment. For this, A53T-a-synuclein-GFP and different constructs incorporating 25Q (Fig. 1A) were coexpressed in S. cerevisiae cells, as indicated. The formation of cytoplasmic inclusions by a-synuclein in yeast is regulated by its expression level [32] . No significant difference was seen in the expression levels of A53T-asynuclein in these sets of cells (Fig. 3A) . In the presence of the empty vector (pRS315-mRFP), A53T-a-synuclein formed characteristic puncta as seen by the localized fluorescence of GFP while more of the protein was seen in the soluble form (diffused fluorescence of GFP) in the presence of FLAG-N17-25Q-mRFP (Fig. 3B) . Different variants of the protein, viz. FLAG-N17-25Q (reporter protein-deleted) and N17-25Q (reporter protein-and purification tag-deleted), were constructed (Fig. 1A) . A53T-a-synuclein-GFP was seen to exist in the soluble form (uniform fluorescence of GFP) in the presence of FLAG-N17-25Q and N17-25Q (Fig. 3B) . The increased localization of A53T-a-synuclein-GFP around the cell membrane and reduced aggregation observed in the presence of these constructs also confirmed the solubilizing effect of these variants. Thus, unlike its role in vitro when chaperone-supplemented medium was required for restoration of activity of the target protein (luciferase) (Fig. 1G and 2B ), N17-25Q was able to retain the soluble conformer of A53T-a-synuclein-GFP and to restore some of its native properties without addition of exogenous chaperones when expressed in a cellular milieu (Fig. 3B) . Aggregation of A53T-a-synuclein in the presence of different constructs was quantified by filter retardation assay. Soluble monomeric protein is able to pass through a cellulose acetate membrane, while insoluble aggregated protein is retained by it [28] . The strongest signals on the membrane were seen in cells expressing A53T-a-synuclein alone or in the presence of empty vector (Fig. 3C ). The intensities of signals for a-synuclein coexpressed with FLAG-N17-25Q-mRFP, FLAG-N17-25Q, or N17-25Q were reduced significantly (Fig. 3C) , confirming that aggregation of a-synuclein was attenuated in the presence of these constructs.
The possibility of interaction of N17-25Q with asynuclein in yeast cells was investigated by coimmunoprecipitation. No direct interaction of luciferase and N17-25Q could be seen when the solubilization of luciferase was carried out in vitro (data not shown). The cell lysate (coexpressing A53T-a-synuclein and FLAG-N17-25Q-mRFP) was pulled down with polyQ antibody coupled to Protein A-Sepharose beads. The pulled down complex was analyzed with a-synuclein antibody. A53T-a-synuclein could be detected in the pulled down fraction (Fig. 3D) . No a-synuclein could be seen in the pulled down fraction of the cell lysate coexpressing a-synuclein and the empty vector. The protein was recovered only in the unbound fraction (Fig. 3D) . Thus, the solubilization and reactivation of a-synuclein probably involves its direct interaction with FLAG-N17-25Q.
Solubilization of A53T-a-synuclein in yeast cells coexpressing empty vector or any of the above constructs was confirmed by FRAP (fluorescence recovery after photobleaching) analysis, which is used to visualize the lateral mobility and dynamics of fluorescent proteins/organelles in living cells. This technique can also be used to determine the state of a protein in the cell, that is, whether it exists in a soluble (higher mobility) or aggregated (lower mobility) form [33] . Recovery after photobleaching in aggregates is less as compared with the soluble species [22, 33, 34] . When A53T-a-synuclein-GFP was expressed in the presence of the empty vector, the recovery of GFP fluorescence after photobleaching was much less as compared with A53T-a-synuclein-GFP coexpressed with FLAG-N17-25Q-mRFP, FLAG-N17-25Q, or N17-25Q (Fig. 3E ). The mobile fraction was less than 15% after recovery in case of coexpression with the empty vector and approximately 95% in case of the constructs incorporating 25Q (Fig. 3E ). The significant increase in mobility of A53T-a-synuclein expressed in the presence of 25Q-containing constructs indicated enhanced solubilization of a-synuclein in these cases. The presence of FLAG tag is deemed to be essential in generating the proteotoxic model of polyglutamine aggregation in yeast [23] . The results above show that this flanking purification tag was not required for the functioning of exon1 fragment as a protein stabilization aid.
Enhanced solubility has beneficial effects on cell survival
Protein misfolding and aggregation have often been correlated with increased level of reactive oxygen species (ROS). Increased oxidative stress has been implicated in the pathogenesis of PD [35, 36] . Intracellular oxidative stress was measured with 2ʹ,7ʹ-dichlorodihydrofluorescein diacetate (DCFH-DA), a cell permeable fluorogenic probe [37] . Increase in fluorescence intensity of the probe was observed in cells coexpressing asynuclein with the empty vector, which was significantly attenuated when cells coexpressed a-synuclein with FLAG-N17-25Q-mRFP, FLAG-N17-25Q, or N17-25Q (Fig. 3F) . These results indicated that the buildup of oxidative stress in the cell associated with aggregation of a-synuclein [36] was relieved when asynuclein was expressed mostly in the soluble form in the presence of N17-25Q variants.
Protein aggregation is one of the major causes of asynuclein-mediated toxicity in models of Parkinson's disease [38] . Cytotoxicity was measured using the nucleic acid stain Sytox Ò orange which is excluded by intact cells and can enter only those cells whose membrane integrity is compromised [39] . Cytotoxicity was significantly reduced in cells coexpressing a-synuclein with FLAG-N17-25Q-mRFP, FLAG-N17-25Q, or N17-25Q as compared with the empty vector ( Fig. 3G) , which was consistent with reduced oxidative stress observed in these cells. As protein aggregation is an important parameter that affects cell survival, monitoring cell viability may be relevant in understanding the beneficial effect of N-terminal wt-htt. Consistent with the above results, viability of yeast cells, coexpressing a-synuclein and FLAG-N17-25Q-mRFP, FLAG-N17-25Q, or N17-25Q, was higher than cells coexpressing A53T-a-synuclein and empty vector (Fig. 3H) . Thus, inhibition of aggregation of A53T-a-synuclein by N-wt-htt fragment led to reduced oxidative stress, attenuated cytotoxicity, and improved cell survival.
Cytoplasmic and nuclear accumulation of wild-type p53 in a functionally inactive form is associated with several human cancers [40, 41] . This transcriptionally inactive protein forms large aggregates which provide a toxic gain of function similar to the phenotype seen in a number of amyloidoses [42, 43] . Wild-type p53 (His 6 -tagged) was expressed constitutively in yeast cells along with FLAG-N17-25Q-EGFP or EGFP (empty vector, E.V.). When coexpressed with p53, EGFP in the empty vector was found to exist as pointed foci, while in case of FLAG-N17-25Q-EGFP, the fluorescent tag (EGFP) showed diffused fluorescence (Fig. 3I) . It has been shown that the presence of aggregated mutant huntingtin (103Q) sequestered FLAG-N17-25Q in an expression level-dependent manner such that FLAG-N17-25Q-EGFP formed fluorescent puncta [22] . In order to confirm if the appearance of FLAG-N17-25Q-EGFP reflected the aggregation status of p53, the aggregation of p53 was monitored by filter retardation assay. Significant decrease in the extent of aggregation of p53 was seen in the presence of FLAG-N17-25Q-EGFP as compared with the empty vector (Fig. 3J ). This was accompanied by reduction in intracellular oxidative stress when p53 and FLAG-N17-25Q-EGFP were coexpressed (Fig. 3K) . Thus, the presence of FLAG-N17-25Q-EGFP was able to rescue the aggregation-induced toxicity of p53 too.
N17 domain is important for the protective ability of N17-25Q
The flanking sequences of the polyglutamine tract, including the 17 amino acids at the N terminus of the protein, are known to play a crucial role in the ability of mutant huntingtin (m-htt) to form aggregates [26, [44] [45] [46] [47] [48] [49] . When full-length huntingtin was expressed in heterologous expression systems, the initiator methionine was missing in all N-terminal peptides and the penultimate alanine was mostly acetylated [50] . Similar results have been reported elsewhere [51] . However, we have numbered the residues in the N17 segment starting with methionine as the first amino acid, as is the common practice in these cases [44, 51, 52] . Mutation of three amino acids in this domain (L4A, L7A, and M8A) abolished the ability of m-htt to form aggregates in vitro [26] . In order to understand if these amino acids of N17 region are also essential for the ability of N-terminal wt-htt fragment to stabilize proteins, these three residues were mutated to generate FLAG-N17(L4A)-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17(M8A)-25Q and their effect on aggregation of luciferase was studied in vitro. Mutagenesis was confirmed by automated sequencing. pYES2-FLAG-N17-25Q (wild-type and mutant sequences) was expressed in S. cerevisiae under a galactose-inducible promoter. Purification of variants of FLAG-N17-25Q from yeast cell lysates was carried out using anti-FLAG M2 affinity gel (Fig. 4A) . Purified firefly luciferase was denatured using guanidinium HCl and aggregation was monitored upon dilution into buffer alone or buffer containing each of the FLAG-N17-25Q variants. Almost complete recovery of luciferase was observed in the supernatants in case of FLAG-N17(L7A)-25Q and FLAG-N17(M8A)-25Q (Fig. 4B) , showing that mutation of these residues did not affect the ability of FLAG-N17-25Q to act as a protein stabilizer. On the other hand, mutation at the fourth residue [FLAG-N17(L4A)-25Q] resulted in only 37% of luciferase being recovered in the supernatant (Fig. 4B) . This was significantly lower than 86% recovery in case of FLAG-N17-25Q (Fig. 2C ) or 91% and 75% recovery for FLAG-N17(L7A)-25Q and FLAG-N17(M8A)-25Q, respectively (Fig. 4B) . This suggests that the fourth residue of N17 region is important in the function of FLAG-N17-25Q as an inhibitor of protein aggregation.
The effect of deletion of N17 segment (along with FLAG) (25Q) on aggregation of A53T-a-synuclein in yeast cells was examined. Deletion of N17 led to reduction in solubility of coexpressed A53T-a-synuclein bỹ 50% as compared with FLAG-N17-25Q-mRFP (Fig. 4C) . Filter retardation showed significant increase in aggregation when A53T-a-synuclein was coexpressed with 25Q as compared with FLAG-N17-25Q-mRFP (Fig. 4D) . Increase in aggregation was accompanied with increase in oxidative stress in these cells (Fig. 4E) . Thus, the presence of the N17 segment is essential for the protein stabilization ability of 25Q.
Loss in helical conformation leads to loss of activity of N17 segment Due to unavailability of the crystal structure for the complete N17-25Q, the secondary structures of the peptides were predicted using PSIPRED [53] . a-Helical geometry was the preferred structural topology of all peptides of FLAG-N17-25Q from different crystal structures (Fig. 4F) . The solution structure of the Nterminal domain of huntingtin (N17-htt) alone (PDB ID: 2LD0) [54] was selected as the template to perform homology modeling of the peptide variants (Fig. 4G) . Restrained homology modeling was adopted in accordance with the predicted secondary structures [55] . The prepared homology models were a-helical for FLAG-N17-25Q and its variants (Fig. 4H) . A transient a-helical structure of the N17 domain has been reported [26] .
Stability of this transient helical fold under dynamic conditions was investigated by molecular dynamics simulation studies. The 10 ns production run was sufficient for the system to attain stability, as indicated by RMSD Densitometric analysis of dots seen on cellulose acetate membrane. A53T-a-synuclein-GFP was expressed in the presence of FLAG-N17-25Q-mRFP (blue bar) or 25Q (orange bar). 100% denotes intensity of aggregated A53T-a-synuclein-GFP expressed in the presence of FLAG-N17-25Q-mRFP. (D) Measurement of oxidative stress in yeast cells coexpressing A53T-a-synuclein-GFP with FLAG-N17-25Q-mRFP (blue bar) or 25Q (orange bar) using 2ʹ,7ʹ-dichlorodihydrofluorescein diacetate (DCFH-DA). 100% denotes normalized fluorescence intensity of 2ʹ,7ʹ-dichlorodihydrofluorescein (DCF) in cells coexpressing a-synuclein with FLAG-N17-25Q-mRFP. ***P < 0.001 against cells coexpressing A53T-a-synuclein and FLAG-N17-25Q-mRFP. Data are represented as mean AE SEM of three independent experiments. (F) Structure of the huntingtin peptide from various crystal structures, i.e., PDB ID 2LD0 (green), 3IOR (cyan), 3LRH (magenta), 4FED (yellow), and 4RAV (orange). (G) Sequence alignment of variants of FLAG-N17-25Q and template 2LD0 (* denotes identical residues and: denotes similar residues). (H) Homology models for peptide variants. The residues targeted for mutation in the sequences are shown as sticks.
analysis for the peptide backbone (Fig. 5A ) and the complete peptide (Fig. 5B) . The B-factor (Fig. 5C ) and atomic fluctuation (Fig. 5D ) analyses showed comparable patterns for FLAG-N17-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17(M8A)-25Q. The residue range 1-20 showed a lower value of B-factor and atomic fluctuation as compared with the rest of the peptide in all the cases. Interestingly, in case of FLAG-N17(L4A)-25Q, the B-factor (Fig. 5C ) and atomic fluctuation (Fig. 5D ) values were higher for the residue range targeted for mutations (i.e. residue number 4-8). The three-dimensional structures of the four peptides after molecular dynamics simulation run of 10 ns are shown in Fig. 5E . The region between residues 4-8 in FLAG-N17-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17(M8A)-25Q was of a-helical geometry, whereas the same region in FLAG-N17(L4A)-25Q adopted a distorted conformation (Fig. 5E ). Thus, this mutation (L4A) in FLAG-N17-25Q caused a structural change in the nearby residues, leading to increasing disorder in this mutant. To evaluate the effect of N-terminal fragment on the secondary structure of polyQ peptide, molecular modeling studies of 25Q (FLAG-and N17-deleted) was taken up. The comparison of the three-dimensional structure before (Fig. 4H) and after (Fig. 5E ) molecular dynamics simulations showed a loss in the helical geometry of N-terminal amino acids (corresponding to the residue range 16-24 of FLAG-N17-25Q) in 25Q.
The total number of H-bonds present per frame in the entire peptide averaged more than five in FLAG-N17-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17 (M8A)-25Q and was reduced to three in FLAG-N17 (L4A)-25Q (Fig. 6A) . This reduction in the number of H-bonds was more prominent in the residue range 1-9 (region where mutations are inserted) (Fig. 6B) . Further, the number of H-bond for the residue pairs with topological distance of 4 (i.e. i th and i + 4 th residues), which is typical of the helical geometry, was calculated to be 17 in case of N17(L4A)-25Q (Fig. 6C) , and was higher in case of the other three peptides, i.e. 27 for FLAG-N17-25Q, 37 for FLAG-N17(L7A)-25Q, and 22 for FLAG-N17(M8A)-25Q (Fig. 6C) . The stability (indicated by the occupancy in Fig. 6C ) was also reduced for the hydrogen bonds responsible for helical geometry in FLAG-N17(L4A)-25Q. Salt bridges are another contributing stabilizing factor in peptides [56] . FLAG-N17-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17(M8A)-25Q showed the presence of at least one salt bridge over the last ns trajectory, whereas in FLAG-N17(L4A)-25Q, no salt bridge was observed (Fig. 6D) . E5-K9 salt bridge pair was present in FLAG-N17-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17(M8A)-25Q but not in FLAG-N17(L4A)-25Q (Fig. 6E) . This indicated that any mutation that causes the breaking of this salt bridge may lead to functional impairment of the designed peptide.
The reduced number of H-bonds between i th and i + 4 th residues (Fig. 6C ) in FLAG-N17(L4A)-25Q indicated a loss in the helical geometry. The analysis of secondary structure over the last ns trajectory showed that the helical structure of the residue range 1-20 was stable in FLAG-N17-25Q, FLAG-N17 (L7A)-25Q, and FLAG-N17(M8A)-25Q and was highly distorted in FLAG-N17(L4A)-25Q (data not shown). The helicity values for FLAG-N17-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17(M8A)-25Q were calculated to be greater than 56%, whereas in case of FLAG-N17(L4A)-25Q, this was reduced to 47% (Table 2 ). This modest reduction in helicity was accompanied by helix to coil transition, thus increasing the coil content from 30% in FLAG-N17-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17(M8A)-25Q to 56% in case of FLAG-N17(L4A)-25Q. The analysis of backbone torsion angles phi and psi for the entire peptide showed significant differences in the residue range 4-8 in various peptides. Therefore, specific comparison for the phi and psi angles of fourth (Fig. 7A,B) , seventh (Fig. 7C,D) , and eighth (Fig. 7E,F) residues (which were targeted for mutation within N17 region) was performed. Interestingly, FLAG-N17(L4A)-25Q (Fig. 7A,B) showed a major difference when compared with the other variants. On an average, the a-helix has a phi angle in the range of À64 AE 7°and psi angle in the range of À41 AE 7° [57] . The average values of these angles in each variant peptide are shown in Table 3 . FLAG-N17(L4A)-25Q showed a strong deviation of the backbone torsion angles from the helical geometry in the residue range 4-8.
Protein contact map is a two-dimensional representation of three-dimensional geometrical distances between residues, where the helix is represented as adjacent parallel lines to the diagonal [58] . The protein contact map for the four variants indicated a stable helix in case of FLAG-N17-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17(M8A)-25Q (as indicated by the adjacent parallel gray lines to the diagonal) in the residue range 1-24 (encircled in red) (Fig. 8A) . The loss of helicity in 25Q was evident in the secondary structure analysis (Table 2 ) and the protein contact map (Fig. 8A) of the peptide over the last ns trajectory. Lower number of hydrogen bonds with topological distance of four residues (i.e. between i th and i + 4 th residues) was seen. These results indicate the significance of the N17 segment in stabilizing the helical structure of the polyQ peptide. In case of FLAG-N17 (L4A)-25Q, this helix was highly distorted. An overall increase in solvent accessible surface area (SASA) of FLAG-N17(L4A)-25Q was also observed (Fig. 8B ). This can be attributed to the helix to coil transition in case of this peptide, leading to increased surface area. In contrast, overall SASA was found to be reduced in the other mutants, viz. FLAG-N17(L7A)-25Q (Fig. 8C) or FLAG-N17(M8A)-25Q (Fig. 8D) . The evidence presented here shows that of the four variants, three (viz. FLAG-N17-25Q, FLAG-N17(L7A)-25Q, and FLAG-N17(M8A)-25Q) acquire a helical configuration, at least transiently, while the fourth (i.e. FLAG-N17(L4A)-25Q) shows a loss in structure. Solid-state NMR assignments unambiguously show that the residues 4-11 in the N17 segment are involved in the formation of the amphipathic helix [59] . Although the differences using simulation studies are modest, these observations provide an explanation for the loss is solubilization ability of FLAG-N17(L4A)-25Q.
Discussion
Release of N-terminal domain, comprising of the N17 region, polyQ tract, and polyP segment, by aberrant splicing or proteolytic cleavage of m-htt is an early and essential step of polyQ toxicity and HD pathology. The importance of sequences flanking the polyglutamine tract has been understood for some time now though mostly in the context of the mutant protein.
In vitro aggregation of the polyQ tract is slowed down in the presence of a C-terminal polyP segment [44] . In the yeast model of HD, the presence of the FLAG epitope tag at either terminus of N-terminal m-htt [23] and deletion of the polyP segment at the C terminus of the polyQ tract [23, 24] are essential to generate the proteotoxic model. The physiological relevance of Nterminal cleavage of wt-htt has not been explored in detail [9] . We found that the absence of the FLAG sequence in N-wt-htt fragment did not result in any deleterious effect on its protein stabilization properties. Analysis of total energy, over the 10 ns (500 frames per ns) trajectory for FLAG-N17-25Q (green), FLAG-N17(L4A)-25Q (red), FLAG-N17 (L7A)-25Q (blue), FLAG-N17(M8A)-25Q (orange), and 25Q (cyan). (E) The three-dimensional structures of different constructs after 10-ns production run. The three residues which were targeted for mutation are shown as stick and are labeled.
Another flanking sequence of polyQ is the N17 domain which modulated aggregation of m-htt not only in yeast but in higher models too. N17 is known to interact with cellular chaperones [60] and lowered the saturation solubility of polyQ tracts and accelerated aggregation while deletion of this domain delayed aggregation of pathogenic exon1 [61] . Addition of free N17 was found to accelerate aggregation of 51Q [26] although later reports failed to reproduce these results [47, 60] . Interestingly, the deletion of N17 domain was found to accelerate aggregation of the polyQ domain in transgenic animal models [48, 49] . One possible Table 2 . Helicity (percent residues present in helix) for the peptides over the last ns trajectory. The secondary structure exhibited by a particular amino acid for maximum number of frames (out of 500 frames) was assigned as the preferred secondary structure of that amino acid.
Secondary structure explanation is the loss of NES (nuclear export signal) sequence which is localized in this domain, leading to the formation of more toxic intranuclear aggregates and explaining the contradictory results observed in vivo.
The isolated N17 segment aggregates very slowly, and aggregation does not proceed beyond the oligomer stage [44] . Interaction of this domain with the polyQ tract is important to generate the aggregation-prone conformer of the latter [26] . The N17 domain can selfassemble and form oligomers, which act as nuclei for fibrillation of the largely unstructured polyQ tract [62] . Crossing the threshold concentration in the next stage leads to an exponential increase in fibril formation, showing the classical sigmoidal pattern of aggregation [44] . This nucleus likely consists of a-helix-rich bundles [46, 52] , which are retained in the mature fibrils [60] . As the local concentration is known to play a predominant role in aggregation kinetics, it may be speculated that a longer Q n stretch, as in the pathogenic variant, would have an increased propensity for aggregation [44] . This may offer an explanation of the apparently contradictory role of N17 when placed with wild-type or mutant polyQ stretch.
CD spectroscopy has shown that the N17 segment has a propensity to adopt the helical conformation when present in multimers [24, 44, 63, 64] . Concentration-dependent studies of N17 CD spectra also suggest that the observation of helicity in the N17 peptide by others is likely to be a result of the high concentrations of the peptide used in these experiments [46] . The importance of formation of this helical core is evident from the observation that the presence of N17 segments along with amyloidogenic polyQ peptide slows down the aggregation process, most likely by providing a competing surface and reducing the local concentration of disordered polyQ segments [47] . Distortion of this a-helical headpiece, for example, by scrambling the sequence, led to inhibition of aggregation in a manner which was strongly correlated with the helicity of the designed competing sequences [47] . Mutations which disrupted the coiled coil structure resulted in reduced aggregation of 72Q [65] . Mutating the hydrophobic residues of the N17 segment led to disruption of the helix and attenuation of aggregation [26] .
The results presented here show that the helical structure of N17 is important for N17-25Q to function as a protein stabilizer. Disruption of the helical propensity in the L4A mutant [FLAG-N17(L4A)-25Q] led to loss of aggregation-inhibitory activity of the protein. Based on the observations regarding formation of helix-rich bundles by the N17 segment [44, 47, 52, 59] , it is equally probable that substitution of the hydrophobic leucine residue at this critical position disrupts the formation of the helical bundle, which results in loss of its aggregation-inhibitory property.
What is the mechanism of stabilization of proteins by N-wt-htt? N17 retains a helical conformation in fibrils, implying that this conformation is a requisite for fibrillation [59] . The earlier report that scrambled sequences of N17 peptide can still inhibit aggregation of polyQ-rich segments, albeit with lower efficiency [47] , suggests that sequence specificity of the client protein may not be of primary importance in inhibition of protein aggregation observed in the present case. A similar propensity, seen with polyQ-b-amyloid hybrid which forms a-helix-rich nucleus to promote aggregation, has helped unravel the mechanism of amyloid fibril formation by this peptide [66] . a-Synuclein is also likely to form helical intermediates on way to formation of mature aggregates [67] , which may interact with the helical N17 segment, inhibiting aggregation of this intrinsically disordered protein. The formation of stable homo-oligomers by p53 is also mediated by a C-terminal helical segment of the protein [68] . Thus, decrease in the local population of aggregation-prone segments by the competing N17 peptide may provide a possible explanation of the reported results.
Mutant huntingtin fragment has been reported to influence the aggregation propensity of a-synuclein [69] . Cotransfection of 25Q and a-synuclein (both BiFC (biomolecular fluorescence complementation) constructs) showed fluorescence in yeast and neuroglioma cells in culture, indicating interaction between the two proteins [69] . This can be correlated with the pull-down experiments reported here (Fig. 3D ). More importantly, the green fluorescence was spread evenly throughout the cell, indicating significant reduction of inclusion formation by a-synuclein [69] . In contrast, clear fluorescent puncta were seen in cells cotransfected with 103Q and a-synuclein BiFC constructs. The interaction between 103Q and a-synuclein was also seen in dopaminergic neurons and photoreceptors in Drosophila [70] where the neuropathology associated with each disease (HD and PD) was exacerbated. Interestingly enough, even in Drosophila, no aggregation was observed in cells coexpressing 25Q and a-synuclein [70] , hinting at the ability of 25Q to attenuate aggregation of a-synuclein.
The ability of 25Q to stabilize aggregation-prone proteins is a concentration-dependent phenomenon. While 25Q was able to reduce the aggregation of 103Q when the expression level of the former was high, a relatively higher level of expression of 103Q led to sequestration of 25Q [22] . Even under these conditions, the toxicity due to 103Q was attenuated. Similar sequestration of a-synuclein by 103Q was also seen in the case of Drosophila [69, 70] . This is important as the concentrations of the peptide employed in this work and earlier [22] are much higher than the cellular concentration of mature huntingtin. Also, the N17-25Q forms a very short stretch of the complete protein, raising doubts of the role of the excised fragment as a folding aid, if any, in a cellular milieu. However, our results suggest a probable role of short amphipathic helical peptides as protein folding aids in the cell. Glutamine-rich domains of proteins like Gts1 and Nab3 (not proteins with QN-rich legitimate prion domains) have recently been identified as suppressors of polyQ-mediated toxicity in Saccharomyces cerevisiae [71] . Coimmunoprecipitation showed that Gts1 interacted directly with 103Q. Gts1 competed with prions in their interaction with client polyglutamine tracts and shifted the aggregation landscape toward less toxic aggregates. In the present case, however, N-wt-htt fragment was able to inhibit aggregation of luciferase in vitro, that is, in the absence of prions, showing that competition with prions may not be the only mode of action of these proteins. N-wt-htt fragment also shows some similarities with small heat shock proteins (sHsps) [25, 72] . The nonspecific nature of protein stabilization is also similar to what is seen with 'nonchaperone proteins', a series of proteins, viz. albumin, lysozyme, a-lactalbumin, b-lactoglobulin, catalase, and pyruvate kinase, which suppressed the fibrillation and reduced the cytotoxicity associated with b-amyloid (Ab) fibrils [73] . Similar suppression of Ab fibrillation has also been shown by tetrameric transthyretin [74] . Thus, proteins without conventional chaperone activity may also display this function in response to a context-dependent requirement.
Methodology
Construction of plasmids
For construction of pYES2-FLAG-N17-25Q (EGFPdeleted), the parent plasmid (pYES2-FLAG-N17-25Q- EGFP) was double digested with BamHI and XbaI to delete EGFP sequence. A stuffer sequence was used to ligate the two ends. For construction of the empty vector pYES2-EGFP, the parent plasmid (pYES2-FLAG-N17-25Q-EGFP) was double digested with KpnI and BamHI to delete FLAG-N17-25Q-htt sequence. A stuffer sequence was used to ligate the two ends. For construction of pRS315-FLAG-N17-25Q-htt (mRFP-deleted), the parent plasmid (pRS315-FLAG-N17-25Q-mRFP) was double digested with SacII and SacI to delete mRFP sequence and a stuffer sequence was used to ligate the two ends. For construction of pRS315-N17-25Q (FLAG-and mRFP-deleted), N17-25Q sequence was amplified from pYES2-FLAG-N17-25Q-EGFP using primers containing 5 0 BamHI and 3 0 SacI sites.
The amplified sequence was used to replace RNQ1-mRFP gene sequence in pRS315-RNQ1-mRFP (received from Prof. Douglas Cyr) digested with the same enzyme pair. For construction of pRS315-25Q (FLAG-N17-deleted), the gene sequence for 25Q was synthesized with flanking regions containing 5 0 BamHI and 3 0 SacI restriction sites.
RNQ1-mRFP gene sequence in pRS315-RNQ1-mRFP was deleted using the same enzyme pair, and the ends of the vector backbone were ligated using the synthesized sequence. For construction of pAD-His 6 -TP53-HA, His 6 -TP53 sequence was amplified from pRSETB-His 6 -TP53 using primers containing 5 0 PstI and 3 0 SmaI sites. The amplified sequence was used to replace HSF1-HA gene sequence in pAD-HSF1-HA (received from Prof. Hiroshi Takagi) digested with the same enzyme pair. Construction of pRS315-FLAG-N17-25Q-mRFP [22] and pRS315-mRFP [75] (empty vector) has been described earlier.
Other plasmids were received as gifts. The pYES2 and p426 vectors contain GAL1 promoter and URA3 as a selection marker, while the pRS315 vector contains CUP1 promoter and LEU2 as a selection marker. The pAD vector contains ADH1 promoter and LEU2 selection marker.
Purification of proteins from Saccharomyces cerevisiae cells
Saccharomyces cerevisiae W303 (MATa leu2-3 112 trp1-1 can1-100 ura3-1 ade2-1 his3-11,15) cells (transformed with pYES2-FLAG-N17-25Q-EGFP, pYES2-FLAG-N17-25Q, and N17 mutants) were grown and the proteins were expressed as described previously using 2% galactose as an inducer (30°C/10 h) [22] . Protein purification was carried out using anti-FLAG M2 affinity gel (Sigma) and monitored by SDS/PAGE, immunoblotting, and dot blot assay. The supernatant containing soluble protein was analyzed by immunoblotting using luciferase polyclonal antibody (Promega). The extent of aggregation was also monitored by measuring the turbidity of the solution containing firefly luciferase at 340 nm over time. Aggregation was also monitored by measuring particle size distribution of luciferase incubated in the absence and presence of FLAG-N17-25Q-EGFP using a zetasizer (Malvern Instruments). Peaks less than 0.1 nm and more than 1000 nm were excluded from analysis. Luciferase was assayed using luciferin as a substrate, according to the protocol described by the manufacturer (luciferase assay system, Promega). Coexpression of A53T-a-synuclein-GFP and FLAG-N17-25Q variants in Saccharomyces cerevisiae
Aggregation of firefly luciferase
Renaturation of denatured firefly luciferase
Saccharomyces cerevisiae cells cotransformed with p426-A53Ta-Syn-GFP and pRS315-FLAG-N17-25Q-mRFP, pRS315-FLAG-N17-25Q, pRS315-N17-25Q, pRS315-25Qt, or empty vector (pRS315-mRFP) were grown and protein was expressed as described earlier [22, 75, 76] . Protein expression was monitored by fluorescence microscopy (E600, Nikon), native PAGE (12% crosslinked nondenaturing polyacrylamide gel) (Typhoon Trio, GE Healthcare), and immunoblotting using a-synuclein (S5566, Sigma) or polyglutamine (MAB1574, Chemicon International) antibody. For measuring cell viability, induced cells (1X10   3   ) were plated on SC-URA-LEU containing 2% dextrose agar plates and grown at 30°C for 1-2 days [22, 77] . The number of viable cells was calculated by considering one colony forming unit as a single cell.
Aggregation of p53
Saccharomyces cerevisiae cells cotransformed with pAD4-His 6 -TP53-HA and pYES2-FLAG-N17-25Q-EGFP or pYES2-EGFP (empty vector) were grown and FLAG-N17-25Q-EGFP or EGFP was expressed as described earlier [22] . p53 was expressed constitutively under ADH1 promoter.
Filter retardation assay
Filter retardation assay of cell lysates was carried out on a cellulose acetate membrane which separates proteins on the basis of size and retains only aggregates [28] . The membrane was probed with a-synuclein antibody (Sigma) or His-antibody (Sigma).
Coimmunoprecipitation assay
The yeast cell lysate coexpressing A53T-a-synuclein and FLAG-N17-25Q-mRFP or empty vector was incubated with polyglutamine antibody and pulled down with Protein A-Sepharose beads (GE Healthcare). The pulled down complex was probed using a-synuclein antibody. The control (yeast cell lysate coexpressing a-synuclein and FLAG-N17-25Q-mRFP) was treated as above without addition of polyglutamine antibody.
Fluorescence recovery after photobleaching (FRAP) analysis
Following induction, cells were mounted on glass slides. A single cell was focused on and the region of interest (ROI) was selected [22, 34] . FRAP was performed as described before [22] .
Measurement of oxidative stress
The level of reactive oxygen species (ROS) in yeast cells was quantified using 2ˊ,7ˊ-dichlorodihydrofluorescein diacetate (DCFH-DA) [37] . The fluorescence of the de-esterified fluorophore was measured at k em 519 nm following k ex 504 nm.
Cell toxicity assay
Toxicity in yeast cells expressing a-synuclein and FLAG-N17-25Q variants was determined using uptake of Sytox Ò orange dye [39] . The fluorescence of the dye was measured at k em 570 nm following k ex 547 nm.
Site-directed mutagenesis
Site-directed mutagenesis in FLAG-N17-25Q was done using QuickChange II Site-Directed Mutagenesis Kit (Agilent Technologies) as described by the manufacturer. Mutagenesis was confirmed by automated sequencing (Eurofins India).
Computational methodology
In order to understand the structural topology and the effect of mutations on the peptide structure, molecular modeling studies were undertaken. For this purpose, FLAG-N17-25Q, FLAG-N17(L4A)-25Q, FLAG-N17 (L7A)-25Q, and FLAG-N17(M8A)-25Q were considered for the molecular modeling studies. To evaluate the secondary structure stabilizing effect of the N17 segment on the polyQ stretch of FLAG-N17-25Q peptide, a truncated peptide structure (25Q) was also considered for the molecular modeling studies. The crystal structure of the complete FLAG-N17-25Q peptide was unavailable in the Protein Data Bank (RCSB/PDB). Therefore, secondary structure prediction was carried out for the peptide sequences using PSIPRED Protein Sequence Analysis Workbench (http://bioinf.cs.ucl.ac.uk/psipred/). Solution structure of the N-terminal domain of huntingtin in 50% 2,2,2-trifluoroethanol (PDB ID: 2LD0) [54] was selected as the template to perform homology modeling of the peptide variants. To evaluate the stability of generated peptide structures under dynamic conditions, molecular dynamics (MD) simulation studies (for 10 ns) were performed using AMBER 12 package [78, 79] . Each system was solvated using TIP3P water [80] with solvation box extended to 20 A in each direction of the solute forming a cubical box that can mimic the periodic boundary conditions in MD simulations. The structural analysis of the generated molecular dynamics simulation trajectories was performed using the Visual Molecular Dynamics (VMD) package and the tools developed in house.
Statistical analysis
All data are expressed as mean AE standard error of mean (SEM) of three independent experiments and analyzed by Student's t-test. Statistically significant difference was considered when the probability (P) value was less than 0.05.
